William E. Smoyer

Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Jürgen Floege, Sean Barbour, Daniel Cattran et al. · Kidney International · 2019 · 257 citations · Full text

Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Brad H. Rovin, Dawn J. Caster, Daniel C. Cattran et al. · Kidney International · 2019 · 181 citations · Full text

Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy

Krzysztof Kiryluk, Elena Sánchez, Francesca Zanoni et al. · Nature Genetics · 2023 · 156 citations · Full text

Genome-wide Association Study, Glomerulonephritis, Genome-wide Association +15

Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization

Richard F. Ransom, Nancy G. Lam, Mark A. Hallett et al. · Kidney International · 2005 · 153 citations

Mechanobiology, Regenerative Medicine, Cell Physiology +11

CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease

Laura Mariani, Andrew S. Bomback, Pietro A. Canetta et al. · American Journal of Kidney Diseases · 2018 · 131 citations · Full text

Glomerular Disease, Glomerulonephritis, Hemodialysis +10